Year 2024 / Volume 116 / Number 7
Letter
Drug-induced liver injury associated to red yeast rice

384-385

DOI: 10.17235/reed.2023.9797/2023

María Desirée García-García, Francisco Bellido Muñoz, Patricia Cordero Ruiz, Paula Fernández Álvarez, María Isabel Carmona Soria, Ángel Caunedo Álvarez,

Abstract
Hepatotoxicity is defined as a liver injury induced by a drug or a non-pharmacological agent like herbal medications or dietary supplements. Red yeast rice is rich in monacolin K, which has the same chemical structure as lovastatin, reason why it has been used for the management of hiperlipidemia. A 62 years old woman presented to the emergency service with 38.5ºC fever, coluric orine and loss of weight in the previous 3 weeks. The patient was taking RYR since the week before to the initial symptoms. Mixed hepatocellular and cholestatic acute hepatitis was diagnosed. Autoimmune liver serology resulted positive. Total DILI RECAM Score was 8 (highly probable DILI). Conservative treatment with exclusion of RYR was decided and during follow-up bilirubin and transaminases gradually dropped off. It has been reported a few cases of hepatitis associated to the use of RYR, promoted by a toxic or immunogenic metabolite. Cross-reactions may justify positive autoantibodies so hepatotoxicity should not be discard as a diagnose.
Share Button
New comment
Comments
No comments for this article
References
1. Serras AS, Rodrigues JS, Cipriano M, Rodrigues AV, Oliveira NG, Miranda JP. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. Front Cell Dev Biol. 2021 Feb 22;9:626805. doi: 10.3389/fcell.2021.626805.
2. Wang TJ, Lien AS, Chen JL, Lin CH, Yang YS, Yang SH. A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus pilosus) Against Hyperlipidemia. Am J Chin Med. 2019;47(2):323-335. doi: 10.1142/S0192415X19500150.
3. Meunier L, Larrey D. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation. Front Pharmacol. 2019 Dec 11;10:1482. doi: 10.3389/fphar.2019.01482.
Related articles

Letter

Turmeric associated liver injury (DILI) with susceptible HLA

DOI: 10.17235/reed.2024.10763/2024

Letter

Fatal HBV-liver failure after withdrawal of antiviral treatment

DOI: 10.17235/reed.2024.10115/2023

Editorial

Hemophilia and hepatology, back to the future

DOI: 10.17235/reed.2024.10105/2023

Letter

Hepatitis B virus reactivation after ibrutinib treatment

DOI: 10.17235/reed.2023.9587/2023

Letter

Autoimmune hepatitis after SARS-C¬¬oV-2 vaccination

DOI: 10.17235/reed.2023.9579/2023

Editorial

New actors come into play against hepatitis delta

DOI: 10.17235/reed.2022.9050/2022

Letter

Lead ingestion, medical emergency and action plan

DOI: 10.17235/reed.2022.9048/2022

Letter

DRESS syndrome secondary to carbamazepine

DOI: 10.17235/reed.2022.8977/2022

Letter

COVID-19 vaccine and autoimmune hepatitis

DOI: 10.17235/reed.2022.8837/2022

Editorial

Orthohepevirus C as causal agent of acute hepatitis in Spain

DOI: 10.17235/reed.2022.8993/2022

Letter

SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?

DOI: 10.17235/reed.2022.8820/2022

Letter

Cefditoren-induced hepatitis

DOI: 10.17235/reed.2022.8801/2022

Letter

Curcumin and curcumoids: hepatoprotection or hepatotoxicity?

DOI: 10.17235/reed.2022.8588/2022

Letter

AMA-positive hepatitis induced by the SARS-CoV-2 vaccine.

DOI: 10.17235/reed.2022.8533/2021

Letter

Ertapenem neurotoxicity in liver transplantation

DOI: 10.17235/reed.2021.8469/2021

Letter

A case of COVID-19 with concomitant infection with hepatitis A

DOI: 10.17235/reed.2021.8372/2021

Editorial

Cases of liver disease lost in the health system: a call to action

DOI: 10.17235/reed.2021.8316/2021

Original

Active search for hepatitis C patients in primary care

DOI: 10.17235/reed.2021.8067/2021

Letter

Autoimmune hepatitis triggered by COVID-19

DOI: 10.17235/reed.2021.8045/2021

Digestive Diseases Image

Emphysematous hepatitis: a very rare entity with a poor prognosis

DOI: 10.17235/reed.2021.7795/2021

Original

Hepatitis C in homeless people: reaching a hard-to-reach population

DOI: 10.17235/reed.2021.7737/2020

Editorial

Screening guide for hepatitis C virus infection in Spain

DOI: 10.17235/reed.2020.7728/2020

Letter

Severe hepatotoxicity secondary to nintedanib

DOI: 10.17235/reed.2020.7585/2020

Letter

Acute hepatitis due to olmesartan: an uncommon entity

DOI: 10.17235/reed.2020.7236/2020

Special Article

Strategy for the Elimination of Hepatitis C in Cantabria

DOI: 10.17235/reed.2020.7108/2020

Editorial

Reflex testing. A key tool for the elimination of hepatitis C

DOI: 10.17235/reed.2020.7201/2020

Letter

Candesartan-induced cholestatic hepatitis: a case report

DOI: 10.17235/reed.2020.6988/2020

Original

A new pattern in hepatitis A virus infection in an urban population

DOI: 10.17235/reed.2020.6526/2019

Original

Quality of life study in asymptomatic patients with hepatitis C

DOI: 10.17235/reed.2019.6339/2019

Letter

Acute seronegative hepatitis C: two case reports

DOI: 10.17235/reed.2019.5921/2018

Case Report

Apixaban-induced liver injury

DOI: 10.17235/reed.2018.5877/2018

Case Report

Sarcoidosis onset simulating a unique hepatic metastasis

DOI: 10.17235/reed.2018.5553/2018

Letter to the Editor

Autoimmune hepatitis as a complication of common variable immunodeficiency

DOI: 10.17235/reed.2018.5280/2017

Letter to the Editor

Canalicular cholestasis induced by anabolic steroids

DOI: 10.17235/reed.2017.4781/2016

Letter to the Editor

The clinical challenge of chronic Q fever with isolated liver involvement

DOI: 10.17235/reed.2017.4633/2016

Case Report

The clinical extremes of autoimmune cholangitis

DOI: 10.17235/reed.2017.4167/2015

Case Report

Glycogenic hepatopathy in young adults: a case series

DOI: 10.17235/reed.2016.3934/2015

Letter to the Editor

PITAVASTATIN: OTHER STATIN TO BE USED AND MONITORED

DOI: 10.17235/reed.2015.3565/2014

Citation tools
García-García M, Bellido Muñoz F, Cordero Ruiz P, Fernández Álvarez P, Carmona Soria M, Caunedo Álvarez Á, et all. Drug-induced liver injury associated to red yeast rice. 9797/2023


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 590 visits.
This article has been downloaded 54 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 21/06/2023

Accepted: 27/06/2023

Online First: 14/07/2023

Published: 08/07/2024

Article Online First time: 23 days

Article editing time: 383 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology